Showing results (1111-1120 of 1,292) with videos related to

Sort By:
Pageof 130
Veterinary and Comparative Oncology|June 6, 2022
Optical coherence tomography for surgical margin evaluation of excised canine cutaneous and subcutaneous tumoursEdward Cheng, Ryan N Jennings, Carolyn L Chen, et al.
Veterinary and Comparative Oncology|June 30, 2022
Multi-institutional retrospective study of canine foot pad malignant melanomas: 20 casesMark D Jeon, Haley J Leeper, Matthew R Cook, et al.
Veterinary and Comparative Oncology|January 11, 2021
Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and catsAmy K LeBlanc, Matthew Atherton, R Timothy Bentley, et al.
Veterinary and Comparative Oncology|November 19, 2020
Hormone receptor expression, clinical and histopathological analysis in feline injection site sarcomasVirgínia V Zanuncio, Lissandro G Conceição, Fabrícia H Loures, et al.
Veterinary and Comparative Oncology|January 6, 2021
Determining agreement between preoperative computed tomography lymphography and indocyanine green near infrared fluorescence intraoperative imaging for sentinel lymph node mapping in dogs with oral tumoursJennifer Wan, Michelle L Oblak, Ann Ram, et al.
Veterinary and Comparative Oncology|January 13, 2021
The selective inhibitor of nuclear export (SINE) verdinexor exhibits biologic activity against canine osteosarcoma cell linesJustin T Breitbach, Darian S Louke, Savannah J Tobin, et al.
Veterinary and Comparative Oncology|February 13, 2020
Impact of radiation dose and pre-treatment pain levels on survival in dogs undergoing radiotherapy with or without chemotherapy for presumed extremity osteosarcomaMichael W Nolan, Noah A Green, Elizabeth M DiVito, et al.
Veterinary and Comparative Oncology|February 13, 2020
Less enhancement and low apparent diffusion coefficient value on magnetic resonance imaging may be helpful to detect canine prostate adenocarcinoma in case seriesToshiyuki Tanaka, Kazuna Ashida, Yasumasa Iimori, et al.
Veterinary and Comparative Oncology|February 20, 2020
Development of synthetic microRNA-214 showing enhanced cytotoxicity and RNase resistance for treatment of canine hemangiosarcomaRyutaro Yoshikawa, Kazuki Heishima, Yoshihito Ueno, et al.
Veterinary and Comparative Oncology|May 15, 2014
COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumoursF Millanta, P Asproni, A Canale, et al.
Pageof 130